Healthy controls | Asthma controls | All athletes | Endurance athletes | Non-endurance athletes | |
---|---|---|---|---|---|
No. of subjects | 53 | 49 | 203 | 80 | 123 |
Males/Females | 23/30 | 15/34 | 142/61 | 60/20 | 82/41 |
Age[years] (median; range) | 28 (20-45) | 29 (18-45) | 26 (18-41) | 25 | 26 |
Baseline FEV1 [% predicted] (median;range) | 110 (77-126) | 100 (75-123) | 103 (66-129) | 106 (82-126) | 100 (66-129) |
ΔFEV1post-salbutamol [%] (median; range) | ND | ND | 4 (0-26) | 4 (0-20) | 4 (0-26) |
MEF 25-75 [% predicted] (median; range) | 104 | 80* | 97 (38-170) | 96 (42-170) | 98 (38-163) |